Safe medicines, sooner rather than later
When existing medicines no longer offer a cure, people want new medicines as soon as possible. At the same time, they want the medicines to be safe. How should the “conditional approval” of medicines take place in a socially responsible way? There is currently the possibility of rapid, “conditional approval” of medicines for severe and as yet untreatable diseases. However, a medicine’s efficacy and safety must be monitored properly after it is put on the market. This project demonstrated that there is much to be gained by actively involving patients and physicians in the monitoring process. Success factors such as short lines of communication and a shared story about the desirability of the process were identified.